other material
confidence high
sentiment positive
materiality 0.45
Genprex announces European Patent Office intent to grant patent for Reqorsa with PD-1 antibodies
Genprex, Inc.
- European Patent Office communicated intent to grant patent for Reqorsa gene therapy combined with PD-1 antibodies for cancer.
- Existing patents already granted in US, Japan, Mexico, Russia, Australia, Chile, China, and Singapore.
- Reqorsa initially developed for lung cancer with approved drugs; shown complementary in preclinical studies.
- Company believes Reqorsa's unique attributes may improve current therapies for lung and other cancers.